Funds · MAZE

Who owns MAZE?

Institutional ownership of Maze Therapeutics Inc. from Form 13F, Q2 2026

162 institutional managers reported holding Maze Therapeutics Inc. (MAZE) in Form 13F filings for Q2 2026, with 58,534,516 shares worth $1.7B. The largest reported holder was Frazier Life Sciences Management, L.P. Managers that filed both quarters added a net 6,310,027 shares (+12.9%). 37 opened new positions and 39 sold out.

Funds holding
162
Value held
$1.7B
New / sold out
37 / 39
Net shares, same filers
+12.9%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of MAZE

FundValueShare of 13F holdingsSharesMove
Frazier Life Sciences Management, L.P.$150M8.6%5,032,915Added
TRV GP IV, LLC$134M7.6%4,473,958Unchanged
ARCH Venture Management, LLC$123M7.0%4,120,053Unchanged
Deep Track Capital, LP$111M6.4%3,732,569Added
BlackRock, Inc.$105M6.0%3,502,841Added
Jupiter Topco LLC$102M5.8%3,408,045First report
T. Rowe Price Investment Management, Inc.$77.7M4.4%2,603,682New
Logos Global Management LP$57.7M3.3%1,935,000Added
Vanguard Capital Management LLC$53.1M3.0%1,778,222Added
a16z Capital Management, L.L.C.$50.8M2.9%1,702,225Unchanged
Venrock Adviser, LLC$47.8M2.7%1,602,034Unchanged
Alphabet Inc.$41.4M2.4%1,388,583Unchanged
Braidwell LP$34.0M1.9%1,140,040New
Farallon Capital Management, L.l.c.$33.1M1.9%1,107,814Added
FMR LLC$31.5M1.8%1,056,959Added
General Catalyst Group Management, LLC$30.9M1.8%1,035,910Unchanged
State Street Corp$29.8M1.7%997,533Added
Driehaus Capital Management LLC$28.5M1.6%954,886Added
TRV GP V, LLC$28.4M1.6%950,800Unchanged
JPMorgan Chase & Co$28.0M1.6%964,011Added
Marshall Wace, LLP$27.3M1.6%914,572Added
Geode Capital Management, LLC$25.6M1.5%858,054Added
Citadel Advisors LLC$25.4M1.5%852,676Added
Casdin Capital, LLC$25.2M1.4%843,857Added
ArrowMark Colorado Holdings LLC$22.9M1.3%767,383Unchanged

Share of 13F holdings is each fund's shares as a share of the 58,534,516 MAZE shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $412M and sold $224M; 66 added and 37 trimmed.

Schedule 13D and 13G filings on MAZE

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about MAZE ownership

Who owns MAZE stock?
162 institutional investment managers reported MAZE positions in their Form 13F filings for Q2 2026, holding 58,534,516 shares worth $1.7B in total. Frazier Life Sciences Management, L.P. reported the largest position.
Are funds buying or selling MAZE?
In Q2 2026, 37 managers opened new MAZE positions, 66 added, 37 trimmed and 39 sold out. Managers that filed in both quarters added a net 6,310,027 shares.
How current is this MAZE institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to MAZE by CUSIP. Options are left out. MAZE news and filings · MAZE insider trades · Top funds